• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺弥漫性大B细胞淋巴瘤生发中心B细胞亚型

Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Subtype of the Thyroid.

作者信息

Waqar Syed Hamza Bin, Khan Anosh Aslam, Coca Guzman Juan, Gottesman Susan Rs, McFarlane Isabel

机构信息

Internal Medicine, State University of New York Downstate Health Sciences University, New York, USA.

Internal Medicine, Dow University of Health Sciences, Karachi, PAK.

出版信息

Cureus. 2021 Oct 19;13(10):e18893. doi: 10.7759/cureus.18893. eCollection 2021 Oct.

DOI:10.7759/cureus.18893
PMID:34820217
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8601090/
Abstract

Non-Hodgkin lymphoma is one of the most common hematological malignancies having both nodal and extranodal sites of involvement. The thyroid gland is one of the rarest primary sites. Most cases of primary thyroid lymphoma are diffuse large B-cell in nature; thus, aggressive and in extreme cases can rapidly lead to airway compromise, especially in patients who have been living with goiter for years. We present one such case of a 64-year-old female who presented with signs of airway compromise, requiring emergent airway intubation and surgical debulking. She was treated with emergent chemotherapy (DA-EPOCH-R regimen), without radiotherapy and this resulted in complete remission.

摘要

非霍奇金淋巴瘤是最常见的血液系统恶性肿瘤之一,可累及淋巴结和结外部位。甲状腺是最罕见的原发部位之一。大多数原发性甲状腺淋巴瘤本质上是弥漫性大B细胞淋巴瘤;因此,病情凶险,在极端情况下可迅速导致气道受压,尤其是多年患有甲状腺肿的患者。我们报告了这样一例64岁女性患者,她出现气道受压症状,需要紧急气管插管和手术减瘤。她接受了紧急化疗(DA-EPOCH-R方案),未进行放疗,最终实现完全缓解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/3d26d6dfdd9a/cureus-0013-00000018893-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/2cb692f105f5/cureus-0013-00000018893-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/7f44e592d5cc/cureus-0013-00000018893-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/637ebfb816ff/cureus-0013-00000018893-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/d30c23fcdbb1/cureus-0013-00000018893-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/a1901c14e4e3/cureus-0013-00000018893-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/3d26d6dfdd9a/cureus-0013-00000018893-i06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/2cb692f105f5/cureus-0013-00000018893-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/7f44e592d5cc/cureus-0013-00000018893-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/637ebfb816ff/cureus-0013-00000018893-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/d30c23fcdbb1/cureus-0013-00000018893-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/a1901c14e4e3/cureus-0013-00000018893-i05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/55d9/8601090/3d26d6dfdd9a/cureus-0013-00000018893-i06.jpg

相似文献

1
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Subtype of the Thyroid.甲状腺弥漫性大B细胞淋巴瘤生发中心B细胞亚型
Cureus. 2021 Oct 19;13(10):e18893. doi: 10.7759/cureus.18893. eCollection 2021 Oct.
2
DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma.DA-EPOCH-R 方案可改善 60 岁以下、生发中心 B 细胞型(GCB)表型和高危国际预后指数(IPI)的弥漫性大 B 细胞淋巴瘤(DLBCL)患者的预后,但其对双表达淋巴瘤无效。
J Cancer Res Clin Oncol. 2019 Jan;145(1):117-127. doi: 10.1007/s00432-018-2771-9. Epub 2018 Oct 16.
3
Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No Mutation by Padlock Probe Hybridization.通过锁式探针杂交未检测到突变的甲状腺结外弥漫性大B细胞淋巴瘤的原发性3型(非ABC、非GCB)亚型
Case Rep Oncol. 2017 Jun 14;10(2):508-514. doi: 10.1159/000477489. eCollection 2017 May-Aug.
4
[Nodal versus extranodal diffuse large B-cell lymphoma: comparison of clinicopathologic features, immunophenotype and prognosis].[结内与结外弥漫性大B细胞淋巴瘤:临床病理特征、免疫表型及预后比较]
Zhonghua Bing Li Xue Za Zhi. 2007 Jul;36(7):470-3.
5
Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.基于淋巴结或结外原发部位受累情况,对弥漫性大B细胞淋巴瘤患者的临床和免疫表型特征以及治疗结果进行分析。
Blood Cells Mol Dis. 2016 Mar;57:42-9. doi: 10.1016/j.bcmd.2015.12.004. Epub 2015 Dec 8.
6
Ki67 Proliferation Index in Germinal and Non-Germinal Subtypes of Diffuse Large B-Cell Lymphoma.弥漫性大B细胞淋巴瘤生发中心型和非生发中心型中的Ki67增殖指数
Cureus. 2021 Feb 4;13(2):e13120. doi: 10.7759/cureus.13120.
7
Germinal-center type B-cell classification and clinical characteristics of Chinese pediatric diffuse large B-cell lymphoma: a report of 76 cases.中国儿童弥漫性大B细胞淋巴瘤生发中心型B细胞分类及临床特征:76例报告
Chin J Cancer. 2013 Oct;32(10):561-6. doi: 10.5732/cjc.012.10198. Epub 2013 Apr 1.
8
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.癌症和白血病协作组 B 针对未经治疗的弥漫性大 B 细胞淋巴瘤的 DA-EPOCH-rituximab 多中心研究,通过分子亚型分析其结果。
Haematologica. 2012 May;97(5):758-65. doi: 10.3324/haematol.2011.056531. Epub 2011 Dec 1.
9
Diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤。
Pathology. 2018 Jan;50(1):74-87. doi: 10.1016/j.pathol.2017.09.006. Epub 2017 Nov 20.
10
Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: Is It a Valid Treatment Option?来那度胺用于复发或难治性弥漫性大B细胞淋巴瘤:它是一种有效的治疗选择吗?
Oncologist. 2016 Sep;21(9):1107-12. doi: 10.1634/theoncologist.2016-0103. Epub 2016 Jul 5.

引用本文的文献

1
Bibliometric analysis and visualization of global research trends in primary thyroid lymphoma via CiteSpace.通过CiteSpace对原发性甲状腺淋巴瘤全球研究趋势进行文献计量分析和可视化
Gland Surg. 2024 Nov 30;13(11):2078-2097. doi: 10.21037/gs-24-317. Epub 2024 Nov 26.

本文引用的文献

1
A Multicenter Retrospective Study of 58 Patients With Primary Thyroid Diffuse Large B Cell Lymphoma.58 例原发性甲状腺弥漫性大 B 细胞淋巴瘤患者的多中心回顾性研究。
Front Endocrinol (Lausanne). 2020 Aug 28;11:542. doi: 10.3389/fendo.2020.00542. eCollection 2020.
2
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit.具有 MYC/BCL2 双打击的弥漫性大 B 细胞淋巴瘤的独特遗传变化揭示了其进化史和异质性分子分级。
Leukemia. 2020 May;34(5):1329-1341. doi: 10.1038/s41375-019-0691-6. Epub 2019 Dec 16.
3
CLINICAL CHARACTERISTICS OF PRIMARY EXTRANODAL VERSUS NODAL DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE COHORT STUDY IN A CANCER CENTER.
原发性结外与结内弥漫性大B细胞淋巴瘤的临床特征:一项癌症中心的回顾性队列研究
Rev Invest Clin. 2019;71(5):349-358. doi: 10.24875/RIC.19003027.
4
Primary Thyroid Lymphoma: An Analysis of the National Cancer Database.原发性甲状腺淋巴瘤:国家癌症数据库分析
Cureus. 2019 Feb 18;11(2):e4088. doi: 10.7759/cureus.4088.
5
Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China.基于结内或结外原发部位的弥漫性大B细胞淋巴瘤的临床特征与预后:中国一家单中心1085例世界卫生组织分类病例分析
Chin J Cancer Res. 2019 Feb;31(1):152-161. doi: 10.21147/j.issn.1000-9604.2019.01.10.
6
Primary thyroid lymphoma: A case report and review of the literature.原发性甲状腺淋巴瘤:一例病例报告及文献综述
Ann Med Surg (Lond). 2016 Dec 21;13:29-33. doi: 10.1016/j.amsu.2016.12.023. eCollection 2017 Jan.
7
Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.结外弥漫性大B细胞淋巴瘤(DLBCL)和原发性纵隔B细胞淋巴瘤:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v91-v102. doi: 10.1093/annonc/mdw175. Epub 2016 Jul 4.
8
Thyroid lymphoma: recent advances in diagnosis and optimal management strategies.甲状腺淋巴瘤:诊断及最佳管理策略的最新进展
Oncologist. 2013;18(9):994-1003. doi: 10.1634/theoncologist.2013-0036. Epub 2013 Jul 23.
9
Primary thyroid lymphoma: a clinical review.原发性甲状腺淋巴瘤:临床综述。
J Clin Endocrinol Metab. 2013 Aug;98(8):3131-8. doi: 10.1210/jc.2013-1428. Epub 2013 May 28.
10
Genotypic and phenotypic differences between nodal and extranodal diffuse large B-Cell lymphomas.结内和结外弥漫性大 B 细胞淋巴瘤的基因型和表型差异。
J Histochem Cytochem. 2011 Oct;59(10):918-31. doi: 10.1369/0022155411417309. Epub 2011 Aug 10.